Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Renal market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

10 Item(s)

Page 1 of 1

  1. Global Renal Denervation Market 2016-2020

    By: Technavio
    , Published: Jul-2016
    , Product code: IRTNTR8281
    The report covers the present scenario and the growth prospects of the global renal denervation market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of renal denervation devices as the demand for these devices is high.
    $2,500.00

  2. Global Continuous Renal Replacement Therapy (CRRT) Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jul-2016
    , Product code: HME-2221115
    The global continuous renal replacement therapy (CRRT) market is growing at the CAGR of 7.69% and will contribute $1290 million till 2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is the fastest growing global continuous renal replacement therapy (CRRT) market, in terms of revenue in forecast period. Increasing geriatric population, rising healthcare infrastructure are the major reasons which boost the Asia Pacific region’s growth in the global continuous renal replacement therapy (CRRT) market. India and China are the two major countries in Asia Pacific region. Europe is a dominating region in global continuous renal replacement therapy (CRRT) market. The major reason which enhances the European region is the increasing prevalence of acute kidney injury patients, approval of anti-coagulants and CRRT machine for multiple applications. North American region is also a growing market for global continuous renal replacement therapy (CRRT) market. The reason being the presence of large number of major players in this area, rising prevalence of kidney failure due to rising diabetes, cancer and other chronic diseases. Rest of the world is showing low market growth, but government initiatives regarding kidney diseases therapies is expected to fuel the market growth in this region. Brazil is the major country in terms of revenue generation
    $3,900.00

  3. Global Genitourinary Partnering 2010-2016: Deal trends, players and financials

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2208
    The Global Genitourinary Partnering 2010 to 2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the genitourinary partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

  4. Global Renal Failure Partnering 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2208ren
    Provides understanding and access to the renal failure partnering deals and agreements entered into by the worlds leading healthcare companies.
    $1,495.00

  5. Global Chronic Kidney Disease Partnering 2010 to 2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2208chr
    Provides understanding and access to the chronice kidney disease partnering deals and agreements entered into by the worlds leading healthcare companies.
    $1,495.00

  6. Renal Insufficiency - Pipeline Review, H2 2015

    By: Global Markets Direct
    , Published: Aug-2015
    , Product code: GMDHC7028IDB
    Global Markets Direct’s, ‘Renal Insufficiency - Pipeline Review, H2 2015’, provides an overview of the Renal Insufficiency’s therapeutic pipeline.
    $2,000.00

  7. Genitourinary Deals and Alliances of 2014

    By: Current Partnering
    , Published: Mar-2015
    , Product code: CP2022gu
    A review of genitourinary partnering trends and comprehensive directory of deals and alliances announced during 2014
    $1,495.00

  8. Renal Insufficiency - Pipeline Review, H1 2015

    By: Global Markets Direct
    , Published: Jan-2015
    , Product code: GMDHC6205IDB
    Global Markets Direct’s, ‘Renal Insufficiency - Pipeline Review, H1 2015’, provides an overview of the Renal Insufficiency’s therapeutic pipeline.
    $2,000.00

  9. Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    By: Global Markets Direct
    , Published: Jan-2015
    , Product code: GMDHC6029IDB
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline.
    $2,000.00

  10. Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

    By: Global Markets Direct
    , Published: Jan-2015
    , Product code: GMDHC6037IDB
    Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)’s therapeutic pipeline.
    $2,000.00

10 Item(s)

Page 1 of 1